Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-1,47
KB-0,35
PKN130,14130,6-6,34
Msft-0,99
Nokia6,9546,9942,04
IBM-0,85
Mercedes-Benz Group AG41,30541,705-3,16
PFE-1,64
07.11.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 06.11.2026 21:58:43
Crocs (CROX.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
152,00 -0,61 -0,94 82 125 572
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 07.11.2026
Popis společnosti

Business Summary: Crocs, Inc. is engaged in the design, development, worldwide marketing, distribution, and sale of casual lifestyle footwear and accessories for all. The Company's brands include Crocs and HEYDUDE. The Crocs Brand's collection contains Croslite material, a proprietary, molded footwear technology. It also uses Croslite material formulations in connection with material technologies used in its visible comfort collections, such as its LiteRide and Free Feel Technology products. The HEYDUDE Brand offers shoes with an iconic and versatile loafer silhouette for many wearing occasions that focus on casualization, comfort-led functionality and personalization. It sells its products in more than 85 countries, through wholesale and direct-to-consumer channels. Its wholesale channel includes domestic and international multi-brand retailers, e-tailers and others. Its direct-to-consumer channel includes Company-operated retail stores, Company-operated e-commerce sites and third-party marketplaces.
Financial Summary: BRIEF: For the six months ended 30 June 2026, Crocs Inc revenues increased 1% to $2.1B. Net income totaled $342.4M vs. loss of $332.2M. Revenues reflect Crocs Brand segment increase of 3% to $1.77B, Retail Sales - Crocs Brand increase of 13% to $880.5M. Net Income reflects HEYDUDE Brand segment income totaling $38.5M vs. loss of $682.7M. Basic Earnings per Share excluding Extraordinary Items increased from -$5.97157 to $6.90727.



  • Poslední aktualizace: 07.11.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, DirectorJason Hollar5301.09.202226.05.2020
Chief Financial OfficerAaron Alt5410.02.202310.02.2023
Corporate Executive - GMPD segmentStephen Mason5516.08.2019
Chief Executive Officer of Pharmaceutical and Specialty Solutions SegmentDeborah Weitzman6119.09.202319.09.2023
Chief Human Resources OfficerValerie Pitteroff55
Executive Vice President, Chief Information Officer, Customer Support ServicesMichelle Greene56
Chief Legal and Compliance OfficerJessica Mayer57